Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 27, 2015
Insider Transaction Report
Form 4
Logerfo Michael
Chief Legal Officer
Transactions
- Award
Common Stock
2015-02-25+4,420→ 48,243 total - Award
Stock Option to Buy
2015-02-25+8,208→ 8,208 totalExercise: $27.15Exp: 2025-02-25→ Common Stock (8,208 underlying)
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by a member of Mr. Logerfo's immediate family sharing the same household. Mr. Logerfo disclaims beneficial ownership of such shares.
- [F2]The option vests in four equal annual installments beginning on February 25, 2016.